Jon Patton | Director of Investor Relations & Communications |
Matt Coffey | President, Chief Executive Officer & Director |
Tom Heineman | Global Head of Clinical Development & Operations |
Andrew de Guttadauro | Global Head of Business Development |
Kirk Look | Chief Financial Officer |
John Newman | Canaccord Genuity |
Patrick Trucchio | H.C. Wainwright |
Good morning and welcome to Oncolytics Biotech's Third Quarter 2021 Conference Call. All participants are now in a listen-only mode. There will be a question-and-answer session at the end of the call. Please be advised that this call is being recorded at the company's request. And I would like to turn the call over to Jon Patton, Director of Investor Relations and Communications.